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SUMMARY 
Introduction: Many patients with breast cancer 
report late with advanced disease. It is not known 
if recent breast awareness education programmes 
have led to a change in this trend at the Korle Bu 
Teaching hospital (KBTH).  
Method: A prospective study of the characteristics 
of breast cancer patients seen by a surgical unit at 
KBTH over a three year period.  
Results: There were 158 patients, 156 females and 
2 males. The age group most commonly affected 
was 40-49. The upper outer quadrant of the breast 
was affected in 67/158 (42.4%) and all quadrants 
affected in 29/158 (18.4%). Ninety one (57.6%) 
had Stage III – IV disease and the average duration 
of symptoms was 10 months. Average tumour size 
was 6cm x 7cm. Diagnosis was by triple assess-
ment with Fine needle aspiration cytology the 
most frequently used pathological investigation. 
Invasive ductal carcinoma was the commonest 
pathological type (115/134). Eighty three (52.5%) 
had mastectomy and 12 (7.6%) had wide local 
excision. Neoadjuvant chemotherapy was given to 
77/123 (62.6%), 5 of whom had complete patho-
logical response. Fifty five (34.8%) were lost to 
follow up: 20 before treatment commenced, 15 
during or after neoadjuvant chemotherapy and 14 
after treatment. Eleven developed lymphoedema. 
There were 42 metastatic events affecting 35 pa-
tients during follow-up, including pleura (11), 
brain (10) and lungs (9). 
Conclusions: Breast cancer continues to affect a 
young population and patients still present late 
with advanced disease. Education needs to be in-
tensified, but research into the reasons for late 
presentation will help address the rea-
sons/misconceptions responsible for this state of 
affairs. 
 






Breast cancer is the leading malignancy in Ghana1. 
It accounts for 15.4% of all malignancies and ap-
pears to be on the increase1. In 1996 12.8% of all 
admissions for malignant neoplasms to the Korle 
Bu Teaching hospital were for breast cancer2. 
There have been many public education pro-
grammes about breast cancer within the last few 
years and some non-governmental organisations 
like Mammocare Ghana, Reach for Recovery and 
the Cancer Society of Ghana have been formed to 
create breast cancer awareness in the general pub-
lic.  
 
Fifty percent or more of Ghanaians with breast 
cancer report to hospital with advanced disease3,4. 
On average they report 8 months or more after first 
noticing a change in their breasts4.  Many of these 
patients are referred to the Korle Bu Teaching 
hospital where they are seen at the surgical out-
patients clinic. It is not known whether public edu-
cation on breast cancer has had an impact on the 
characteristics of breast cancer cases reporting to 
the surgical units of the Korle Bu Teaching hospit-
al. We prospectively studied the case histories of 
patients referred to one unit at Korle Bu over a 
three-year period to determine any changes in 
breast cancer presentation. 
 
METHODS 
Patients with carcinoma of the breast referred to 
one of the four surgical units at the Korle Bu 
Teaching hospital were studied prospectively over 
a three-year period to determine the ages, present-
ing complaint, duration of symptoms, stage at 
presentation and the site of the tumour. The treat-
ment given – type of surgery, chemotherapy and 
referral to radiotherapy – was also studied. 
 
Patients were first seen at the Out-patients clinic 
where a detailed history was taken and fine needle 
aspiration cytology (FNAC) performed on all 
breast lumps, except for very obvious fibroadeno-
mas in young women under 20. Core biopsies 
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were performed on the ward if FNAC was not 
possible or if FNAC results were equivocal. The 
indications for incision biopsy were ulcerated tu-
mours/skin nodules, Paget’s disease of the nipple 
and inflammatory breast cancer, where no mass 
was palpable. Excision biopsies were performed in 
theatre under local anaesthetic. Mammograms 
and/or ultrasound were requested especially if 
there was no palpable lump (e.g. some cases of 
inflammatory breast cancer) or if breast conserva-
tion surgery was contemplated. Investigations to 
determine metastases were carried out once a di-
agnosis of breast cancer was made. These included 
a chest X-ray, liver function tests, ultrasound scan 
of the liver and bone scan. X-ray of symptomatic 
bones was requested when bone scans were not 
available. Each patient was staged by the Ameri-
can Joint Committee on Cancer (AJCC) TNM 
staging5. A treatment plan was then drawn for each 
patient. Where further discussion was required the 
patient was referred to the Korle Bu Breast Clinic 
for discussion by a multidisciplinary team. 
 
Patients requiring surgery were booked for surgery 
while those requiring neoadjuvant chemotherapy 
(those with locally advanced tumours) were sche-
duled to have it on the ward on specific days. Sur-
gery was scheduled for the latter patients after 
two-to-four cycles of chemotherapy, depending on 
tumour response. Patients with early-stage tumours 
had surgery followed by adjuvant chemotherapy. 




There were 158 patients seen, comprising 156 
women and 2 men. The ages ranged from 24 to 75 
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Figure 1 Age distribution of breast cancer patients 
 
Sites of tumour: The cancer was on the left side 
in 76 cases and right in 82. The sites involved are 
shown in Table 1. 
Table 1 Sites of tumour 
 
Site Number Percentage 
Upper outer quadrant* 67 42.4 
Central 31 19.6 
Total (All quadrants)** 29 18.4 
Lower outer quadrant 15 9.5 
Upper inner quadrant 9 5.7 
Lower inner quadrant 5 3.2 
Axillary nodes*** 2 1.3 
Total 158 100 
*     Includes axillary tail 
**   Includes inflammatory cancer with no obvious mass 
*** No breast mass 
 
Stage of presentation: The stage of presentation 
by AJCC TNM is shown in Table 2.  
 
Table 2 TNM stage of tumours 
 




T Tx* 3 
 Tis 1 
 T0 2 
 T1 8 
 T2 43 
 T3 30 
 T4a 1 





N N0 55 
 N1 71 
 N2 22 
 N3 10 
M Mx 151 
 M1 7 
* Tumour size could not be determined in 3 previously excised tu-
mours 
 
Duration of symptoms: The interval between 
when symptoms were first noticed to time of pres-
entation ranged from 2 weeks to 5 years. The mean 
duration was 10 months and the median was 7 
months.  
 
Tumour size: The mean tumour size was 6x7 cm. 
 
Method of pathological diagnosis: Overall 96 
patients were diagnosed by FNAC, 50 by excision 
biopsy, 6 by core biopsy and 6 by incision biopsy. 
Of the 50 excision biopsies, 26 were excised be-
fore being referred to KBTH. Of the remaining 24, 
14 had FNAC which were reported as either in-
conclusive or benign. Incision biopsies were used 
in the diagnosis of 3 ulcerated tumours, 2 inflam-
matory breast cancers and 1 Paget’s disease of the 
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nipple. FNAC was successful in diagnosing 87.3% 
of the cancers. 
 
Pathology: A full histological diagnosis (follow-
ing core biopsy or mastectomy/wide local excision 
specimen) was possible in 134 cases. The others 
were diagnosed as having malignant cells by 
FNAC but did not have tissue diagnosis because 
they did not have surgery. The tumour types are 
shown in Table 3. Twenty four of the 55 patients 
with clinically negative nodes (cN0) had cancer on 
pathology (pN1). Conversely 16 patients with cN1 
nodes had no cancer on pathology (pN0). All pa-
tients with N2+ nodes clinically did have cancer 
on pathology. 
 
Table 3 Pathological type of tumours 
 
Pathological type Number Percentage 
Invasive ductal 115 85.8 
Invasive lobular 7 5.2 
Ductal Carcinoma In Situ 3 2.2 
Medullary 3 2.2 
Mucinous 2 1.5 
Adenosqamous 2 1.5 
Adenocarcinoma 1 0.7 
Apocrine carcinoma 1 0.7 
Total 134 99.8 
 
Treatment:  
a. Surgery: Eighty three patients (52.5%) had 
mastectomy and 12 (7.6%) had wide local ex-
cision. Twenty two (13.9%) were not suitable 
for breast surgery due to advanced disease and 
41 (25.9%) either absconded or refused sur-
gery. Nine of the mastectomy specimen 
showed no residual tumour. Five of these fol-
lowed neoadjuvant chemotherapy and 4 were 
mastectomies following pathologically incom-
pletely excised tumours.  
 
Two patients had latissimus dorsi myocutane-
ous flap breast reconstruction at the time of 
mastectomy. Both operations were done to 
cover a large defect in the skin following re-
moval of the breast.  
 
Level II axillary clearance was the routine me-
thod of axillary dissection employed in both 
mastectomy and wide local excision opera-
tions. 
 
b. Chemotherapy: Of the 158 patients seen, 123 
needed chemotherapy. Seventy seven of them 
(62.6%) had neoadjuvant and 46 (37.4%) had 
adjuvant chemotherapy. The commonest cyc-
lical combination therapy regime used was 
CAF (Cyclophosphamide, Adriamycin [dox-
orubicin] and 5-Fluorouracil) in 78 patients 
(64.2%). The number of cycles given ranged 
from 1 (defaulters) to 6. The mean number of 
cycles given was 4. 
 
c. Radiotherapy: Forty one patients were referred 
for post-operative radiotherapy on account of 
the advanced stage of their tumours on presen-
tation. Other criteria for referral are listed in 
Table 4. 
 






Following wide local excision 12 
T4 Tumours, post-mastectomy 25 
Incompletely excised tumour. E.g. 
muscle involvement 
14 
≥ 4 lymph nodes involved with tu-
mour 
9 
Metastatic disease (Brain, bones) 15 
Note: Some of the groups overlap 
 
Defaulting patients: Fifty five patients (34.8%) 
were lost to follow-up during the period of the 
study. Of these 14 (8.9%) completed their treat-
ment. Twenty patients (12.7%) defaulted before 
treatment; 6 (3.8%) defaulted and returned after 
many months with Stage 4 disease; 15 (9.5%) dis-
continued treatment during or after neoadjuvant 
chemotherapy. 
 
Table 5 Sites of metastases during 3 year period 
 
Site Number 







Complications: Eleven patients developed lym-
phoedema following surgery. There were 42 me-
tastatic events affecting 35 patients during the fol-
low-up period (Table 5). One patient had diather-
my burns on her thigh during surgery due to faulty 
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diathermy equipment. Nausea and vomiting was 
present to a degree in all patients who received 
chemotherapy. All patients receiving Adriamycin 
developed alopecia. Seromas that needed aspira-
tion occurred in 23/95 patients following axillary 
node dissection. Fourteen others had mild seromas 
that settled spontaneously. 
 
DISCUSSION 
Cancer of the breast affects a relatively young 
population in Ghana. The majority of our patients 
were in the fifth decade (40-49), similar to pre-
vious studies4,6 and this confirms the occurrence of 
breast cancer in Ghana about a decade earlier than 
in Caucasians1,4.  
 
Male breast cancer remains relatively uncommon. 
Although most texts put the male incidence at 1% 
of breast cancers7 the proportion in various coun-
tries is variable. Analysis of pathology specimen in 
Ghana puts the incidence at 2%8 and in Jos (Nige-
ria) it has been reported as high as 8.6%9. In this 
series it is 1.3%.  
 
The upper outer quadrant was the commonest site 
involved in breast cancer. The number of patients 
with cancer involving the whole breast, 29/158 
(18.4%) is a reflection of how advanced most of 
the tumours were. Some of these patients had in-
flammatory breast cancer with no definite palpable 
lump. 
 
Stage of disease 
As Table 2 shows, not many patients presented 
with early disease. Ninety one patients (57.6%) 
had advanced disease at presentation. Seventy pa-
tients (45.2%) had either peau d’orange or ulce-
rated tumours. The tumours were large, 6-7 cm on 
average. Earlier studies in Ghana have shown 
similar proportion of breast cancer patients pre-
senting with advanced disease3,4. It thus appears 
that public education has so far failed to change 
this unfortunate trend. 
 
Duration of symptoms 
Although we did not find out the reasons for late 
reporting, the mean duration of symptoms of 10 
months is worrying. It is slightly longer than was 
found from the same hospital five years earlier4, 
indicating no impact of breast awareness education 
programmes. Some of the patients reporting to us 
after two years had had previous hospital treatment 
and defaulted, presumably to try alternative treat-
ment.  
  
Method of diagnosis 
Pathological diagnosis was mainly by fine needle 
aspiration cytology.  Unfortunately some of the 
patients referred to the unit had already had exci-
sion biopsy, many of them incompletely excised. 
Inadequately excised cancers often posed a prob-
lem. Sometimes the pathologist gave no informa-
tion about resection margins. Where the tumour 
had not been completely excised the patient 
needed further surgery, often mastectomy. Some 
of these patients could have been spared a mas-
tectomy if the initial biopsy had not been by sim-
ple excision.  
 
It is recommended that breast lumps be properly 
investigated by triple assessment10. The sensitivity 
of FNAC was only 87.3%, and therefore clinicians 
should always consider clinical evaluation and 
imaging (when necessary) before making or ex-
cluding the diagnosis of breast cancer. As shown 
by this study other forms of pathological diagnosis 
(core biopsy or incision biopsy) may sometimes be 
preferable. The resort to excision biopsies of all 
breast lumps including clinically malignant ones 
should be discouraged.  
 
Incision biopsies were done in 6 patients. These 
patients had ulcerated tumours (3), inflammatory 
breast cancer (2) and Pagets disease (1). The two 
patients with inflammatory cancer had no palpable 
breast lumps. Their FNACs were negative as were 
core biopsies; the diagnosis was only confirmed by 
incision biopsy of the skin of the breast. Incision 
biopsies for all breast lumps should, however, be 
discouraged. The wounds might not heal, as hap-
pened in the case of two patients who presented 
with T4b disease (skin involvement) which they 
did not have before incision biopsy.  
 
Treatment 
Mastectomies constituted most of the operations 
for breast cancer. Wide local excision (breast con-
servation) was done in only 12 out of the 95 pa-
tients who had surgery. Breast conservation sur-
gery therefore accounted for 12.6% (12/95) of our 
surgical procedures compared to up to 70-85% in 
the western world11. This reflects the advanced 
state of tumours at presentation.  
 
The criteria followed for breast conservation 
were1,12:  
§ Lumps not greater than 4cm.  
§ Lumps not centrally placed (i.e. not behind 
nipple/areola) 
§ No other tumour focus demonstrated in the 
breast (by mammogram or ultrasound) 
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§ Tumour not poorly differentiated 
§ Patient willing and able to have radiotherapy 
to the breast after surgery 
§ Breast not too small (Favourable breast: tu-
mour ratio) 
§ Patient wanted breast conservation (provided 
other conditions were met). Some patients 
preferred mastectomy! 
 
Patients treated by wide local excision always had 
level II axillary clearance as part of the surgical 
procedure and referred for post-operative radiothe-
rapy to the remaining breast. Where tumours had 
already been completely excised before referral to 
our unit, axillary clearance was carried out before 
referring for radiotherapy.  
 
Neoadjuvant chemotherapy was given to patients 
with locally advanced disease before surgery. Ear-
ly stage tumours were treated by surgery followed 
by adjuvant therapy. Seventy seven of the patients 
(62.6%) had neoadjuvant chemotherapy, a reflec-
tion of the level of advanced disease. Unfortunate-
ly some patients defaulted when their tumours 
became smaller and surgery was due. Five of the 
77 who had neoadjuvant chemotherapy had com-
plete pathological response (no pathological evi-
dence of cancer in the breast) at mastectomy, 
showing the effectiveness of the CAF combination 
therapy used. 
 
Some patients may be suitable for breast recon-
struction. It is then preferable to undertake breast 
reconstruction and mastectomy at the same opera-
tive session11,12. Several options can be chosen, 
which range from simple positioning of an ex-
pander to the use of musculocutaneous flaps (latis-
simus dorsi [LD] or Tranverse rectus abdominis 
myocutaneous [TRAM]), and skin-sparing mas-
tectomy11-13. Our plastic surgeons performed LD 
myocutaneous flaps for 2 patients on request. 
Breast reconstruction is currently not routinely 
offered to patients by our unit or other units at the 
Korle Bu Teaching Hospital. The provision of 
more operative time and acquisition of breast re-
construction skills by our breast surgeons would 
help us perform more reconstruction procedures. It 
is possible that some our patients refuse mastect-





There was a high rate of default in the patients 
studied. Twenty patients (12.7%) stopped attend-
ing as soon as they were informed about the diag-
nosis. Fifteen others (9.5%) started with neoadju-
vant chemotherapy and stopped attending either 
when there was improvement or when mastectomy 
was due. For these two groups of patients the fear 
of or misconceptions about mastectomy were 
probably the main reasons for defaulting. Six pa-
tients (3.8%) defaulted and returned after many 
months with incurable disease. These patients re-
turned with requests for mastectomy for their ulce-
rated breasts, but were refused surgery because of 
the advanced nature of the disease and distant me-
tastases. 
 
Education, aimed at dispelling misconceptions 
about mastectomy and offering breast reconstruc-
tion may lead to a reduction in the number of pa-
tients defaulting. Surgeons must revise their ap-
proach of dealing with breast cancer patients14. 
These patients go through emotions of denial, feel-
ing of injustice, guilt, failure, betrayal and doom14. 
Their cultural beliefs might address their state of 
vulnerability leading to them turning to traditional 
healers14. Adequate initial counselling is therefore 
likely to decrease the 12.7% of patients who 
stopped attending once the diagnosis was made. 
 
Complications 
The pleura, brain and lungs were the commonest 
sites of metastases in our patients during follow-
up. Lymphoedema occurred in eleven patients but 
was serious in only five. No new cases of lym-
phoedema were detected in patients who had su-
pra/infraclavicular lymph node radiotherapy. The 
commonest complications following chemothera-
py were nausea, vomiting and alopecia. Bone mar-
row suppression was not marked.  
 
Further studies are needed to determine why pa-
tients present late. Patients’ fears and misconcep-
tions will have to be addressed in breast awareness 
education programmes if they are to have an im-
pact. The high rate of default among our patients 
calls for a more personalized approach for follow-
up, using breast care nurses and counsellors to 




There has been no improvement in breast cancer 
presentation at the KBTH over the past 5-10 years, 
in spite of breast awareness programmes. Patients 
still present with advanced disease many months 
after symptoms appear.. The 40-49 decade remains 
the peak age at presentation. This study has also 
identified a high rate of default among patients. 
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Further research is needed to address these issues 
and change the trend. 
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